Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

Share Price Information for Tissue Regenix Group (TRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.00
Bid: 63.00
Ask: 67.00
Change: -0.50 (-0.76%)
Spread: 4.00 (6.349%)
Open: 65.50
High: 65.50
Low: 65.00
Prev. Close: 65.50
TRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First day dealings in Tissue Regenix

29 Jun 2010 08:06

RNS Number : 4005O
IP Group PLC
29 June 2010
 



PRESS RELEASE 29 June 2010

 

IP Group plc - Tissue Regenix Group plc first day dealings on AIM after reverse takeover

 

IP Group plc (LSE: IPO) ("IP Group"), the developer of intellectual property based businesses, is pleased to note that Tissue Regenix Group plc ("Tissue Regenix" or "the Company"), a medical technology company that is held within the IP Group portfolio and a spin-out company from the University of Leeds, has today joined AIM via a reverse takeover of Oxeco plc (AIM: OXE) ("Oxeco") (the "Reversal").

 

First day dealings on AIM of Ordinary Shares ("Ordinary Shares") in Tissue Regenix commence today. Concurrent with the Reversal, Tissue Regenix has completed a placing raising proceeds (before expenses) of £4.5 million.

 

Tissue Regenix (AIM: TRX) is a medical technology company focused on the development and commercialisation of acellular tissue replacement products to address the chronic global shortfalls in donor tissue availability. Tissue Regenix uses its proprietary technology platform, dCELL®, to remove cells and other components from human and animal tissue allowing them to be used without anti-rejection drugs to replace worn out or diseased body parts.

 

The three priority markets for the application of the technology are vascular, cardiac and orthopaedics. Tissue Regenix's lead product is the dCELL® Vascular Patch, intended to be permanently implanted into the human body for vascular repair. The company intends to start marketing the dCELL® Vascular Patch in Europe during the second half of 2010. The next product on which Tissue Regenix intends to focus is the dCELL® Meniscus, for the repair of damaged knee meniscus.

 

IP Group is beneficially interested in 71,703,123 Ordinary Shares in Tissue Regenix (worth £3.6 million at the placing price of 5 pence per share), representing 15.4% of Tissue Regenix's enlarged issued share capital. The Reversal will result in a fair value gain to IP Group of £1.4 million.

 

Tissue Regenix is the fourteenth of IP Group's portfolio companies to have listed on either AIM or PLUS Markets and is the second IP Group portfolio company to have achieved a listing this year following Ilika plc's flotation in May.

 

For more information, please contact:

IP Group

www.ipgroupplc.com

Alan Aubrey, Chief Executive Officer

+44 (0) 20 7444 0050

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062 / 07979 853 802

Financial Dynamics

 

Ben Atwell, John Dineen

+44 (0) 20 7831 3113

About IP Group

 

IP Group is an intellectual property (IP) commercialisation company that specialises in commercialising university technology. Founded in 2001, IP Group listed on AIM in October 2003 and moved to the Official List in June 2006. It has made two acquisitions to date - Techtran, a company set up to commercialise university intellectual property under a long term contract with the University of Leeds, in 2005 and Top Technology Ventures, an investment adviser to early stage technology venture capital funds, in 2004.

 

IP Group has formed long-term partnerships with ten universities - the University of Oxford, King's College London, CNAP/University of York, the University of Leeds, the University of Bristol, the University of Surrey, the University of Southampton, Queen Mary (University of London), the University of Bath and the University of Glasgow.

 

The Company's portfolio is diverse with exposure to five main sectors - Energy & Renewables, Medical Equipment & Supplies, Pharma & Biotech, IT & Communications and Chemicals & Materials. To date, thirteen portfolio companies have listed on the AIM market of the London Stock Exchange, one on PLUS Markets and there have been four trade sales.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGUUUQUPUUMB
Date   Source Headline
30th Jun 20061:53 pmRNSHolding(s) in Company
19th Jun 20063:03 pmRNSHolding(s) in Company
12th Jun 20062:30 pmRNSHolding(s) in Company
9th Jun 20064:45 pmRNSAdditional Listing
9th Jun 20061:09 pmRNSHolding(s) in Company
6th Jun 20063:25 pmRNSHolding(s) in Company
6th Jun 20063:23 pmRNSAdditional Listing
31st May 20064:28 pmRNSHolding(s) in Company
26th May 20062:10 pmRNSContract Win
25th May 20067:04 amRNSAGM Statement
18th May 20062:49 pmRNSHolding(s) in Company
18th May 20061:49 pmRNSHolding(s) in Company
16th May 20061:18 pmRNSAdditional Listing
2nd May 200610:25 amRNSAcquisition
27th Apr 20061:54 pmRNSHolding(s) in Company
25th Apr 20062:26 pmRNSAdditional Listing
25th Apr 200611:47 amRNSAdditional Listing
18th Apr 20065:42 pmRNSAdditional Listing
12th Apr 20065:36 pmRNSHolding(s) in Company
12th Apr 20065:33 pmRNSGrant of Options
12th Apr 200612:06 pmRNSPlayback Details
11th Apr 200610:46 amRNSHolding(s) in Company
11th Apr 20067:01 amRNSAcquisition
7th Apr 20062:31 pmRNSHolding(s) in Company
6th Apr 20063:19 pmRNSHolding(s) in Company
6th Apr 20063:16 pmRNSHolding(s) in Company
3rd Apr 20062:52 pmRNSTrading Update
30th Mar 20062:59 pmRNSHolding(s) in Company
29th Mar 200610:08 amRNSDirector/PDMR Shareholding
29th Mar 20068:56 amRNSAdditional Listing
28th Mar 200611:02 amRNSHolding(s) in Company
28th Mar 200610:39 amRNSHolding(s) in Company
22nd Mar 200611:34 amRNSHolding(s) in Company
16th Mar 20067:04 amRNSFinal Results
14th Mar 20068:12 amRNSHolding(s) in Company
9th Mar 20065:04 pmRNSNotice of Results
9th Mar 20061:33 pmRNSAdditional Listing
7th Mar 20063:59 pmRNSAdditional Listing
6th Mar 200612:46 pmRNSHolding(s) in Company
6th Mar 200611:02 amRNSHolding(s) in Company
2nd Mar 200611:06 amRNSHolding(s) in Company
1st Mar 20063:29 pmRNSHolding(s) in Company
28th Feb 200611:09 amRNSHolding(s) in Company
28th Feb 20069:52 amRNSHolding(s) in Company
16th Feb 20061:47 pmRNSHolding(s) in Company
10th Feb 20065:27 pmRNSHolding(s) in Company
10th Feb 20065:25 pmRNSAdditional Listing
9th Feb 20067:02 amRNSNew Business Wins
6th Feb 20064:41 pmRNSHolding(s) in Company
6th Feb 20064:40 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.